Evidence map›Paper›PMID 32356024›Full record

ArticleVirchows Archiv : an international journal of pathology2020

Histological changes associated with pyloric and pseudopyloric metaplasia after Helicobacter pylori eradication.

Yasuhiro Wada, Ryoji Kushima, Masaaki Kodama, Masahide Fukuda, Kensuke Fukuda, Kazuhisa Okamoto, Ryo Ogawa, Kazuhiro Mizukami, Tadayoshi Okimoto, Kazunari Murakami

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Gastric epithelial histology and precancerous conditions.World journal of gastrointestinal oncology · 2022
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yasuhiro WadaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Oita, 879-5593, Japan.
Ryoji KushimaDepartment of Pathology, Faculty of Medicine, Shiga University of medical science, Otsu, Shiga, 525-2192, Japan. ryoji.kushima@gmail.com.
Masaaki KodamaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Oita, 879-5593, Japan.
Masahide FukudaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Oita, 879-5593, Japan.
Kensuke FukudaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Oita, 879-5593, Japan.
Kazuhisa OkamotoDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Oita, 879-5593, Japan.
Ryo OgawaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Oita, 879-5593, Japan.
Kazuhiro MizukamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Oita, 879-5593, Japan.
Tadayoshi OkimotoDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Oita, 879-5593, Japan.
Kazunari MurakamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Oita, 879-5593, Japan.
Oita University · JPShiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyloric metaplasia (PM) and pseudopyloric metaplasia (PPM) are metaplastic changes resulting in pyloric-type glands in the gastric oxyntic mucosa that mainly occur in chronic gastritis caused by Helicobacter pylori (H. pylori) infection. Focusing on PM and PPM, we classified the histological changes in gastric mucosa according to the Updated Sydney System, using 314 biopsy specimens of gastric greater curvature of the middle body before H. pylori eradication (HPE). Next, the numbers of PM and PPM glands were counted in 47 specimens, and subjects were followed up over 10 years after HPE. PPM was recognized jointly with inflammation, activity, atrophy, and intestinal metaplasia, but PM was recognized more frequently than PPM as atrophy and intestinal metaplasia progressed. Both PM and PPM regressed significantly within 6 years after HPE. Additionally, we demonstrated that PM and PPM are not always coincident with spasmolytic polypeptide-expressing metaplasia (SPEM). In conclusion, PM and PPM are considered different modulations of the same line of differentiation, which are both reversible, with PM potentially emerging from PPM upon progression.

Indexed as

BiopsyCell DifferentiationChronic DiseaseGastric MucosaGastritisHelicobacter InfectionsHelicobacter pyloriHumansIntercellular Signaling Peptides and ProteinsMetaplasiaRetrospective StudiesTime FactorsTreatment OutcomeIntercellular Signaling Peptides and Proteinsspasmolytic polypeptideHelicobacter pyloriPseudopyloric metaplasiaPyloric metaplasiaSpasmolytic polypeptide-expressing metaplasia (SPEM)

Identifiers

PMID32356024
OpenAlexW3021479321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.